國立虎尾科技大學 |

The path from biomarker discovery to regulatory qualification

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The path from biomarker discovery to regulatory qualification/ Federico Goodsaid, Strategic Regulating Intelligence, Regulatory Affairs, Vertex Pharmaceuticals, Washingon DC, USA, William B. Mattes, PharmPoint Consulting, Poolesville, Maryland, USA.
作者:	Goodsaid, Federico.
其他作者:	Mattes, William B.
出版者:	Amsterdam :Elsevier/Academic Press, : 2013.,
面頁冊數:	xiii, 192 p. :ill. ; : 24 cm.;
標題:	Biochemical markers. -
電子資源:	http://www.sciencedirect.com/science/book/9780123914965
ISBN:	9780123914965 (electronic bk.)

The path from biomarker discovery to regulatory qualification
Goodsaid, Federico.

The path from biomarker discovery to regulatory qualification[electronic resource] /Federico Goodsaid, Strategic Regulating Intelligence, Regulatory Affairs, Vertex Pharmaceuticals, Washingon DC, USA, William B. Mattes, PharmPoint Consulting, Poolesville, Maryland, USA. - Amsterdam :Elsevier/Academic Press,2013. - xiii, 192 p. :ill. ;24 cm.

Includes bibliographical references and index.

The Path from Biomarker Discovery to Regulatory Qualification is a unique guide that focuses on biomarker qualification, its history and current regulatory settings in both the US and abroad. This multi-contributed book provides a detailed look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists. Members of the regulatory, pharmaceutical and biomarker development communities will benefit the most from using this book-it is a complete and practical guide to biomarker qualification, providing valuable insight to an ever-evolving and important area of regulatory science. Contains a collection of experiences of different groups taking different types of biomarkers to different levels of qualification and provides insightful case studies of an important area of regulatory science Focuses on practical advice, concepts, strategies and overall outcomes to support those working toward biomarker qualification for clinical use Offers a valuable resource for members of the regulatory, pharmaceutical and biomarker development communities.

ISBN: 9780123914965 (electronic bk.)

LCCN: 2012276154Subjects--Topical Terms:

582469
Biochemical markers.

LC Class. No.: R853.B54 / G66 2013

Dewey Class. No.: 610.28

The path from biomarker discovery to regulatory qualification
LDR:02161cam a2200241 a 4500 001 797418
005 20140702181956.0
008 150518s2013 enka sb 001 0 eng d
010 $a 2012276154
020 $a 9780123914965 (electronic bk.)
020 $a 9780123914965
035 $a (OCoLC)ocn832288614
035 $a 14000544
040 $a BTCTA $b eng $c BTCTA $e rda $d YDXCP $d UKMGB $d IXA $d OCLCF $d DLC
041 0 $a eng
042 $a lccopycat
050 0 0 $a R853.B54 $b G66 2013
082 0 0 $a 610.28 $2 23
100 1 $a Goodsaid, Federico. $3 1004546
245 1 4 $a The path from biomarker discovery to regulatory qualification $h [electronic resource] / $c Federico Goodsaid, Strategic Regulating Intelligence, Regulatory Affairs, Vertex Pharmaceuticals, Washingon DC, USA, William B. Mattes, PharmPoint Consulting, Poolesville, Maryland, USA.
260 $a Amsterdam : $b Elsevier/Academic Press, $c 2013.
300 $a xiii, 192 p. : $b ill. ; $c 24 cm.
504 $a Includes bibliographical references and index.
520 $a The Path from Biomarker Discovery to Regulatory Qualification is a unique guide that focuses on biomarker qualification, its history and current regulatory settings in both the US and abroad. This multi-contributed book provides a detailed look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists. Members of the regulatory, pharmaceutical and biomarker development communities will benefit the most from using this book-it is a complete and practical guide to biomarker qualification, providing valuable insight to an ever-evolving and important area of regulatory science. Contains a collection of experiences of different groups taking different types of biomarkers to different levels of qualification and provides insightful case studies of an important area of regulatory science Focuses on practical advice, concepts, strategies and overall outcomes to support those working toward biomarker qualification for clinical use Offers a valuable resource for members of the regulatory, pharmaceutical and biomarker development communities.
650 0 $a Biochemical markers. $3 582469
700 1 $a Mattes, William B. $3 1004547
856 4 0 $u http://www.sciencedirect.com/science/book/9780123914965